-11%

Kre-Alkalyn 2500 Mega Caps Olimp - 120 capsules

OLIMP
€55.99 €49.99
  • High Bioavailability
  • Buffered Molecule
  • 120 capsules
€49.99

Kre-Alkalyn Olimp

Capsules with buffered creatine monohydrate, food supplement intended to meet the expenditure of intense muscular effort, especially for sports people.

The product contains patented type of creatine monohydrate, characterized by its high bioavailability. In muscle tissues creatine is bound with phosphate to phospho-creatine. Consumption of creatine increases physical performance during short-term, high intensity, repeated exercise bouts (refers to the daily intake of 3 g creatine).

Olimp Kre-Alkalyn Nutritional Facts

Nutrition declaration 1 capsule / 2 capsules / 4 capsules

  • Energy 21 kJ/ 5 kcal 41 kJ/ 10 kcal 84 kJ/ 20 kcal
  • Fat of which: saturates < 0,5 g < 0,1 g < 0,5 g < 0,1 g < 0,5 g < 0,1 g 
  • Carbohydrate of which: sugars 0 g 0 g 0 g 0 g 0 g 0 g 0 g
  • Protein 0,2 g / 0,4 g / 0,8 g
  • Salt 0,02 g / 0,03 g / 0,07 g
  • Buffered creatine monohydrate KRE-ALKALYN®, of which: creatine 1250 mg 1100 mg / 2500 mg / 2200 mg 5000 mg / 4400 mg 88 g

Ingredients: buffered creatine monohydrate KRE-ALKALYN®, bulking agent – microcrystalline cellulose; anti-caking agent – magnesium salts of fatty acids; capsule – gelatine.

The product is designed for physically active, adult people and sportsmen.

Recommended use: on training days – take 1-2 capsules in the morning and 1-2 capsules before training; on non-training days – take 1-2 capsules before breakfast, drinking with a large amount of water.

Not suitable for children and young people. An increase of weight may happen. Do not exceed the recommended daily dose. Food supplements should not be used as a substitute for a varied and balanced diet. A varied and balanced diet and a healthy lifestyle are recommended.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
Have Questions?Ask An Expert
MEGAPUMP uses cookies to understand how you use our site and to improve your experience. By continuing to use our site, you consent to the use of cookies.
Please confirm your subscription with following email
This email has been registered